glp 1 and gip receptors glp-1 receptor agonist Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Demonstrated metabolic effects of GIP, – GLP-1 and GIP receptors signal

Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)

Advanced Ergonomics : Our pens are designed for easy handling, ensuring that even patients with limited dexterity can administer doses safely

Researchers continue to discover new ways GLP-1 influences the body, making it one of the most widely studied hormones involved in metabolism today

However, the data also shows that results vary widely from person to person